Ezia Bello
Mario Negri Institute for Pharmacological Research(IT)Istituti di Ricovero e Cura a Carattere Scientifico(IT)
Publications by Year
Research Areas
Fibroblast Growth Factor Research, Sarcoma Diagnosis and Treatment, Angiogenesis and VEGF in Cancer, Cancer Cells and Metastasis, Protein Degradation and Inhibitors
Most-Cited Works
- → Lurbinectedin reduces tumour-associated macrophages and the inflammatory tumour microenvironment in preclinical models(2017)150 cited
- → A covalent PIN1 inhibitor selectively targets cancer cells by a dual mechanism of action(2017)143 cited
- → E-3810 Is a Potent Dual Inhibitor of VEGFR and FGFR that Exerts Antitumor Activity in Multiple Preclinical Models(2011)142 cited
- → Mode of action of trabectedin in myxoid liposarcomas(2013)128 cited
- → Chemical characterization of Iraqi propolis samples and assessing their antioxidant potentials(2011)94 cited
- → Comparison of in vitro and in vivo biological effects of trabectedin, lurbinectedin (PM01183) and Zalypsis® (PM00104)(2013)61 cited